Oncimmune Holdings plc (LON:ONC), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT®platform technology announced today that it has received confirmation from HMRC that the Ordinary Share are regarded as a qualifying holding for the purposes of Part 6 of the Income Tax Act 2007 (the “VCT Condition”).
Consequently, the 833,333 Ordinary Shares that were conditionally placed as part of the placing of 4,166,667 Ordinary Shares announced on 27 September 2017 (“Delayed Completion Placing Shares”) will now be issued at the placing price of £1.20.
Under the terms of the placing, admission of the Delayed Completion Placing Shares is to occur within 5 business days of satisfaction of the VCT Condition. Admission is therefore expected at 8.00 am on 28 November 2017.
Following Admission of the Delayed Completion Placing Shares, the Oncimmune Holdings plc enlarged issued share capital will comprise 55,216,071 Ordinary Shares of 1 pence each with voting rights in the Company. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in the interest in, the share capital of the Company under the FCA’s Disclosure and Transparency Rules.
